This Hims & Hers Move Could Disrupt Competing Firms
Hims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
Concise guidance on identifying budgeting flaws early and applying simple corrections to avoid debt and build security.
24,558 articlesHims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
Nvidia faces strong AI-driven demand and a robust roadmap that could push long-term targets higher. Analysts weigh ne...
Nasdaq-100 levered ETFs are back in focus as markets swing. While 3x exposure offers amplified moves, daily resets ma...
Three ETFs have stood out in 2026 by delivering positive returns while the S&P 500 retreats. RSP, NLR, and VXUS are t...
DraftKings stock slides as a Senate measure targets prediction markets, while Penn Entertainment holds steady amid re...
VFVA has posted solid gains by targeting cheap U.S. equities, but a hidden volatility risk lies in its deep value app...
CrowdStrike delivered a solid ARR beat but guided below lofty expectations, triggering a about 7% drop in CRWD shares...
The latest consumer sentiment 56.4 reading sets the tone for retail stocks and the VanEck Retail ETF (RTH) in 2026. I...
Andreessen Horowitz's crypto unit closes its fifth fund at $2.2 billion, signaling a patient, long-horizon bet on cry...
The FDA approved two fruit-flavored vape lines from a Los Angeles company, a notable policy reversal that comes as po...
Latin American ETFs EWZ and EWW are leading a regional rally in 2026, powered by stronger commodity markets and a shi...
Two Dividend Kings anchor Berkshire Hathaway's core holdings as Greg Abel takes the helm. Analysts say Coca-Cola and ...